MedPath

SPIKEVAX BIVALENTE ORIGINAL/OMICRON BA.4-5 (50 MICROGRAMOS/50 MICROGRAMOS)/ML DISPERSION INYECTABLE

SPIKEVAX BIVALENTE ORIGINAL/OMICRON BA.4-5 (50 MICROGRAMOS/50 MICROGRAMOS)/ML DISPERSION INYECTABLE

Pending
Register Number

1201507006

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Oct 26, 2022

Dosage Form

DISPERSIÓN INYECTABLE

Route: VÍA INTRAMUSCULAR

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1201507006
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (2)

DAVESOMERANActive
Quantity: 0,05 mg
Name: DAVESOMERAN
ELASOMERANActive
Quantity: 0,05 mg
Name: ELASOMERAN

ATC CLASSIFICATION (3)

J07B
J07BN
J07BN01

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.